Boston Scientific Corp (BSX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2003 | 03-2003 | 12-2002 | 09-2002 | 06-2002 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 410,000 | 294,000 | 260,000 | 259,000 | 144,000 |
| Receivables | 478,000 | 452,000 | 435,000 | 399,000 | 406,000 |
| Inventories | 239,000 | 241,000 | 243,000 | 257,000 | 283,000 |
| Income taxes - deferred | N/A | N/A | 168,000 | N/A | N/A |
| Other current assets | 248,000 | 253,000 | 0 | 259,000 | 241,000 |
| TOTAL | $1,375,000 | $1,240,000 | $1,208,000 | $1,174,000 | $1,074,000 |
| Non-Current Assets | |||||
| PPE Net | 678,000 | 656,000 | 636,000 | 627,000 | 627,000 |
| Investments And Advances | 373,000 | 0 | 210,000 | 0 | 0 |
| Intangibles | 2,440,000 | 2,437,000 | 2,367,000 | 2,173,000 | 2,187,000 |
| Other Non-Current Assets | 55,000 | 279,000 | 29,000 | 293,000 | 229,000 |
| TOTAL | $3,546,000 | $3,372,000 | $3,242,000 | $3,093,000 | $3,043,000 |
| Total Assets | $4,921,000 | $4,612,000 | $4,450,000 | $4,267,000 | $4,117,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 66,000 | 71,000 | 66,000 | 528,000 | 463,000 |
| Accrued Expenses | 498,000 | 446,000 | 639,000 | N/A | N/A |
| Other current liabilities | 192,000 | 150,000 | 28,000 | 238,000 | 260,000 |
| TOTAL | $1,107,000 | $1,092,000 | $923,000 | $1,034,000 | $1,059,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 974,000 | 826,000 | 847,000 | 840,000 | 835,000 |
| Other Non-Current Liabilities | 188,000 | 219,000 | 113,000 | 107,000 | 126,000 |
| TOTAL | $1,162,000 | $1,045,000 | $1,060,000 | $947,000 | $961,000 |
| Total Liabilities | $2,269,000 | $2,137,000 | $1,983,000 | $1,981,000 | $2,020,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 823,258 | 820,334 | 819,896 | 815,683 | 813,766 |
| Common Shares | 4,000 | 4,000 | 4,000 | 4,000 | 4,000 |
| Retained earnings | 1,605,000 | 1,491,000 | 1,394,000 | 1,290,000 | 1,133,000 |
| Other shareholders' equity | -88,000 | -118,000 | -127,000 | -116,000 | -125,000 |
| TOTAL | $2,652,000 | $2,475,000 | $2,467,000 | $2,286,000 | $2,097,000 |
| Total Liabilities And Equity | $4,921,000 | $4,612,000 | $4,450,000 | $4,267,000 | $4,117,000 |